NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of New Era Energy & Digital, Inc. (NASDAQ: NUAI) resulting from allegations that New Era Energy & Digital may have issued materially misleading business information to the investing public.

This article compares RITM's recent dividend per share rates, yield percentages, and several dividend sustainability metrics to 17 mREIT peers. This includes an analysis of RITM's quarterly core earnings/earnings available for distribution (“EAD”) which directly impacts the company's dividend sustainability. This article also projects RITM's dividend sustainability for Q1 2026 – Q2 2026 (including specific per share amounts).

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 17, 2026 .

iShares National Muni Bond ETF offers high credit quality exposure but delivers a modest 3.15% yield, reflecting its index-tracking approach. MUB's strategy of holding only high-grade munis and broad market tenor results in middling returns, especially compared to more selective, credit-risk-focused funds. I believe credit risk is overpriced in munis; taking more nominal credit risk, as in SHYM or NMCO, can deliver 1–2% higher yields with manageable risk.

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Freeport-McMoRan Inc. (NYSE: FCX) between February 15, 2022 and September 24, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

SAN FRANCISCO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact attorneys before the January 5, 2026, Lead Plaintiff Deadline.

MU has continued its surge to all-time highs. Strong earnings and rising memory prices are fueling upward momentum. Despite the run-up, the stock likely has more room to run in 2026.

Alphabet unit Waymo said on Tuesday it will expand first responder engagement, improve its emergency response protocols and roll out updates to allow its vehicles to navigate intersections more decisively, following incidents of stalled Waymo robotaxis after a San Francisco power outage.

Oil slipped in early Asian trade. Prices were likely to remain volatile, with moves dominated by geopolitical developments, Kudotrade said.

RenaissanceRe Holdings offers two investment-grade preferred stocks, RNR.PR.G and RNR.PR.F, both trading below par and near historical lows. RNR.PR.G and RNR.PR.F provide higher yields and capital appreciation potential compared to RNR's OTC bonds, with spreads to Treasuries of 1.77% and 1.59%, respectively. RNR maintains strong financials: $54.5B in assets, $18.97B equity, and investment-grade credit ratings from major agencies.

A preliminary injunction in federal court cited the First Amendment, handing a win to tech companies like Apple and Google.

NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Heritage Commerce Corp (NASDAQ: HTBK) related to its sale to CVB Financial Corp. Under the terms of the proposed transaction, Heritage shareholders are expected to receive 0.6500 shares of CVB common stock for each share of Heritage.

Limoneira Company (LMNR) Q4 2025 Earnings Call Transcript

The Vanguard Russell 2000 Value Index ETF offers low-cost, broad small-cap value exposure but lacks a profitability filter, increasing portfolio risk. VTWV allocates heavily to micro-cap, unprofitable companies, resulting in negative return on invested capital and below-peer profitability metrics. Peers like FNDA, AVUV, and VBR, which screen for profitability or cash flows, deliver superior volatility-adjusted returns and higher Sharpe ratios than VTWV.

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year.

International Seaways, Inc. is not fully insulated from headwinds, but its prudent fleet management ensures efficiency and profitability. Its well-balanced exposure to spot and time charter rates provides it with enough flexibility and security to protect its topline performance. Its robust Balance Sheet ensures it can sustain its increasing operating capacity and dividend payments.

The company's first-ever chief brand officer, Asad Ayaz, is Bob Iger's pick to depoliticize America's best-known entertainment company.

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Headline of release should read: Klarna Group plc Securities Class Action Result of Understated Risks and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC (instead of Klarna Group plc Securities Fraud Class Action Result of Understated Risks and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC). The updated release reads: KLARNA GROUP PLC SECURITIES CLASS ACTION RESULT OF UNDERS.

Profit-taking quashed a mini-rally for space stocks. They were flying higher in recent days because of a political development.

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia Marketed under AQVESME brand name in the U.S. for thalassemia indication; PYRUKYND® (mitapivat) remains the U.S. brand name for PK deficiency indication AQVESME expected to be available in late January 2026, following AQVESME REMS program implementation Company will host investor conference call and webcast tomorrow, December 24 at 8:00 a.m. ET CAMBRIDGE, Mass.